Literature DB >> 33704756

Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors.

Johanna Detzner1, Gottfried Pohlentz1, Johannes Müthing2.   

Abstract

Glycosphingolipids (GSLs) consist of a ceramide (Cer) lipid anchor, which is typically composed of the long-chain aminoalcohol sphingosine (d18:1) and a fatty acid (mostly C16-C24) and a sugar moiety harboring to a great extent one to five monosaccharides. GSLs of the globo-series are well-recognized receptors of Shiga toxins (Stxs) released by Stx-producing Escherichia coli (STEC). Receptors for the Stx subtypes Stx1a and Stx2a are globotriaosylceramide (Gb3Cer) and globotetraosylceramide (Gb4Cer), whereby Gb3Cer represents their high-affinity and Gb4Cer their low-affinity receptor. In addition to Gb3Cer and Gb4Cer, Gb5Cer and Forssman GSL are further receptors of the Stx2e subtype rendering Stx2e unique among the various Stx subtypes. Thin-layer chromatography (TLC) is a convenient and ubiquitously employed method for analyzing GSL mixtures of unknown composition. In particular, TLC immunochemical overlay detection allows for sensitive identification of Stx-binding GSLs in complex mixtures directly on the TLC plate. For this purpose, specific anti-GSL antibodies or Stxs themselves in conjunction with anti-Stx antibodies can be used. The described protocols of antibody-mediated detection of TLC-separated globo-series GSLs and corresponding identification of Stx-binding globo-series GSLs will provide detailed advice for successful GSL analysis and particularly highlight the power of the TLC overlay technique.

Entities:  

Keywords:  AB5 toxin; Antibody; Forssman GSL; Gb3Cer; Gb4Cer; Mass spectrometry; Overlay technique; Stx subtypes

Mesh:

Substances:

Year:  2021        PMID: 33704756     DOI: 10.1007/978-1-0716-1339-9_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  54 in total

Review 1.  Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium.

Authors:  Martina Bielaszewska; Helge Karch
Journal:  Thromb Haemost       Date:  2005-08       Impact factor: 5.249

Review 2.  Shiga Toxin Producing Escherichia coli.

Authors:  Allen Bryan; Ilan Youngster; Alexander J McAdam
Journal:  Clin Lab Med       Date:  2015-03-18       Impact factor: 1.935

Review 3.  The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There.

Authors:  Stefanie Kampmeier; Michael Berger; Alexander Mellmann; Helge Karch; Petya Berger
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

Review 4.  Shiga Toxin/Verocytotoxin-Producing Escherichia coli Infections: Practical Clinical Perspectives.

Authors:  T Keefe Davis; Nicole C A J Van De Kar; Phillip I Tarr
Journal:  Microbiol Spectr       Date:  2014-08

Review 5.  Pathogenesis of Shiga-toxin producing escherichia coli.

Authors:  Angela Melton-Celsa; Krystle Mohawk; Louise Teel; Alison O'Brien
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 6.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

Review 7.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

8.  Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature.

Authors:  Flemming Scheutz; Louise D Teel; Lothar Beutin; Denis Piérard; Glenn Buvens; Helge Karch; Alexander Mellmann; Alfredo Caprioli; Rosangela Tozzoli; Stefano Morabito; Nancy A Strockbine; Angela R Melton-Celsa; Maria Sanchez; Søren Persson; Alison D O'Brien
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

Review 9.  Enterohaemorrhagic Escherichia coli in human medicine.

Authors:  Helge Karch; Phillip I Tarr; Martina Bielaszewska
Journal:  Int J Med Microbiol       Date:  2005-10       Impact factor: 3.473

Review 10.  Enterohemorrhagic E. coli (EHEC) pathogenesis.

Authors:  Y Nguyen; Vanessa Sperandio
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

View more
  3 in total

1.  Ingenious Action of Vibrio cholerae Neuraminidase Recruiting Additional GM1 Cholera Toxin Receptors for Primary Human Colon Epithelial Cells.

Authors:  Johanna Detzner; Charlotte Püttmann; Gottfried Pohlentz; Johannes Müthing
Journal:  Microorganisms       Date:  2022-06-20

Review 2.  Enterohemorrhagic Escherichia coli and a Fresh View on Shiga Toxin-Binding Glycosphingolipids of Primary Human Kidney and Colon Epithelial Cells and Their Toxin Susceptibility.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

3.  Primary Human Renal Proximal Tubular Epithelial Cells (pHRPTEpiCs): Shiga Toxin (Stx) Glycosphingolipid Receptors, Stx Susceptibility, and Interaction with Membrane Microdomains.

Authors:  Johanna Detzner; Anna-Lena Klein; Gottfried Pohlentz; Elisabeth Krojnewski; Hans-Ulrich Humpf; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2021-07-28       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.